Inventor
MINTER RALPH
GB15 patents
⚠️ This page may combine multiple inventors who share the name “MINTER RALPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDIMMUNE LTD
10 patentsUS9938356B2Apr 10, 2018
Binding molecules specific for CD73 and uses thereof
MEDIMMUNE LTD26 citations92
US10370436B2Aug 6, 2019
Anti-pseudomonas Psl binding molecules and uses thereof
MEDIMMUNE LTD5 citations82
US10287362B2May 14, 2019
Binding molecules specific for CD73 and uses thereof
MEDIMMUNE LTD10 citations82
US11203633B2Dec 21, 2021
Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
MEDIMMUNE LTD2 citations71
US10844114B2Nov 24, 2020
Anti-Pseudomonas Psl binding molecules and uses thereof
MEDIMMUNE LTD3 citations71
US10556968B2Feb 11, 2020
Binding molecules specific for CD73 and uses thereof
MEDIMMUNE LTD2 citations71
US12428473B2Sep 30, 2025
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
MEDIMMUNE LTD0 citations61
US11525012B2Dec 13, 2022
Binding molecules specific for CD73 and uses thereof
MEDIMMUNE LTD0 citations60
US11192948B2Dec 7, 2021
Compositions and methods for inhibiting cancer stem cells
MEDIMMUNE LTD0 citations54
US10329345B2Jun 25, 2019
Stabilized angiopoietin-2 antibodies and uses thereof
MEDIMMUNE LTD0 citations52
MEDIMMUNE LLC
3 patentsUS9580509B2Feb 28, 2017
Multispecific and multivalent binding proteins and uses thereof
MEDIMMUNE LLC9 citations82
US9884902B2Feb 6, 2018
CTLA-4 variants
MEDIMMUNE LLC9 citations77
US10597439B2Mar 24, 2020
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
MEDIMMUNE LLC4 citations71